Victoria L. Brown - 20 Jan 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Program Team Lead
Signature
/s/ David Watson, attorney-in-fact for Victoria Brown
Issuer symbol
APLS
Transactions as of
20 Jan 2023
Net transactions value
-$73,495
Form type
4
Filing time
24 Jan 2023, 15:57:32 UTC
Previous filing
28 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability $73,495 -1,412 -5.7% $52.05 23,556 20 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares withheld for tax on a restricted stock unit release.
F2 Includes 124 shares from 10/31/22 ESPP purchase.